You are here: Industry Insights > Metformin Hydrochloride Extended-Release Tablets

News List

Granules Issues Recall of Metformin Hydrochloride Extended-Release Tablets americanpharmaceuticalreview
July 21, 2020
Granules Pharmaceuticals is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of NNitrosodimethylamine (NDMA) ...
Lupin recalls diabetes treatment drug in US expresspharma
July 13, 2020
The company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg products in the US.
Teva Initiates Recall of Metformin Hydrochloride Extended-Release Tablets americanpharmaceuticalreview
June 18, 2020
Teva Pharmaceuticals is voluntarily recalling fourteen (14) lots of Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, 100 and 1000 count bottles ...
Marksans Recalls Metformin Hydrochloride Extended-Release Tablets, USP 500mg americanpharmaceuticalreview
June 16, 2020
Marksans Pharma Limited, India is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004, to the consumer level.
Apotex Issues Recall of Metformin Hydrochloride Extended-Release Tablets 500mg americanpharmaceuticalreview
June 05, 2020
Apotex is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level.